Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) has approved TORISEL(TM) (temsirolimus) for patients with advanced renal cell carcinoma (RCC).

Posted : Thu, May 31, 2007

   Pediatricians at Johns Hopkins Children's Center, and around the country alert us about the health of our children.

Posted : Sat, Dec 30, 2006